| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00012 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.00017 | 1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 8.8e-05 | 1 |